Eliquis and Disease complication - a phase IV clinical study of FDA data

Summary:

Disease complication is reported as a side effect among people who take Eliquis (apixaban), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Opsumit, and have Primary pulmonary hypertension.

The phase IV clinical study analyzes which people have Disease complication when taking Eliquis. It is created by eHealthMe based on reports of 189,425 people who have side effects when taking Eliquis from the FDA, and is updated regularly.

What is Eliquis?

Eliquis has active ingredients of apixaban. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 191,861 Eliquis users. Check the latest studies of Eliquis.

What is Disease complication?

Disease complication is found to be associated with 320 drugs and 451 conditions by eHealthMe. Check the latest studies of Disease complication.

On Aug, 13, 2026

189,425 people reported to have side effects when taking Eliquis.
Among them, 36 people (0.02%) have Disease complication.

Could Eliquis cause Disease complication?

Among these 36 people:

How long have people been on Eliquis when they have Disease complication? *

What is the gender of people who have Disease complication when taking Eliquis? *

female: 57.14 %
male: 42.86 %

What is the age of people who have Disease complication when taking Eliquis? *

What are other drugs people take besides Eliquis? *

What are other side effects people have besides Disease complication? *

Dyspnea (difficult or laboured breathing): 9 people, 25.00%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 8 people, 22.22%
Pneumonia: 7 people, 19.44%
Nausea (feeling of having an urge to vomit): 6 people, 16.67%
Oedema (fluid collection in tissue): 6 people, 16.67%
Swelling: 6 people, 16.67%
Diarrhea: 6 people, 16.67%
Nasopharyngitis (inflammation of the nasopharynx): 5 people, 13.89%
Fatigue (feeling of tiredness): 5 people, 13.89%
Nausea And Vomiting: 5 people, 13.89%

What are the existing conditions these people have? *

Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 17 people, 47.22%
Multiple Myeloma (cancer of the plasma cells): 3 people, 8.33%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 2 people, 5.56%
Liver Disorder (liver diseases): 2 people, 5.56%
Idiopathic Pulmonary Fibrosis (chronic lung disease): 2 people, 5.56%
Parkinson's Disease: 1 person, 2.78%
Pancreatic Carcinoma (pancreatic cancer): 1 person, 2.78%
Osteoporosis (bones weak and more likely to break): 1 person, 2.78%
Non-Alcoholic Steatohepatitis (liver inflammation caused by a build up of fat in the liver): 1 person, 2.78%
Lung Neoplasm Malignant (cancer tumour of lung): 1 person, 2.78%

* Approximation only. Some reports may have incomplete information.

Do you take Eliquis and have Disease complication?

- Check whether Disease complication is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Eliquis:

Eliquis (191,861 reports)

Browse all side effects of Eliquis:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Disease complication:

Disease complication (320 drugs)

Browse all the conditions that are associated with Disease complication:

Disease complication (451 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on apixaban (the active ingredients of Eliquis) and Eliquis (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.